Skip to main content
Log in

Experiences with sodium thiosulfate after intracarotid infusion of cisplatin and BCNU for malignant gliomas

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

The treatment of malignant gliomas with cisplatin has been shown to be of benefit. In order to reduce the side effects of the drug, we employed the use of sodium thiosulfate in ten patients one hour after cisplatin infusion and continued for 6 h. Side effects from this population of patients were compared with those side effects experienced with 13 patients not receiving thiosulfate. No real difference in number or severity of side effects from cisplatin was observed between the two groups although nephrotoxicity appeared to be reduced in the patients who received thiosulfate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Pfeifle CE, Howell SB, Felthouse RD, Woliver TBS, Andrews PA, Markman M, Murphy MP: High-dose cisplatin with sodium thiosulfate procection. J Clin Oncol 3:237–244, 1985.

    Google Scholar 

  2. Howell SB, Pfeifle CE, Wung WE, Olshen RA, Lucas WE, Yon JL, Green M: Intraperitoneal cisplatin with systemic thiosulfte protection. Ann Int Med 97:845–851, 1982.

    Google Scholar 

  3. DeConti RC, Toftness BR, Lange RC, Creasey WA: Clinical and pharmacological studies with cis-diamminedichloroplatinum (II). Cancer Res 33:1310–1315, 1973.

    Google Scholar 

  4. Himmelstein KJ, Patton TF, Belt RJ, Taylor S, Repta AJ, Sternson LA: Clinical kinetics of intact cisplatin and some related species. Clin Pharmacol Ther 29:658–664, 1981.

    Google Scholar 

  5. Gormley PE, Bull JM, LeRoy AF, Cysyk R: Kinetics of cis-dichlorodiammineplatinum. Clin Pharmacol Ther 25 (3):351–357, March, 1979.

    Google Scholar 

  6. Walker EM Jr, Gale GR: Methods of reduction of cisplatin nephrotoxicity. Ann Clin Lab Sci 11:397–410, 1981.

    Google Scholar 

  7. Kapp J, Vance R: Supraophthalmic carotid infusion for recurrent gliomass: rationale, technique, and preliminary results for cisplatin and BCNU. J Neuro-Oncol 3:5–11, 1985.

    Google Scholar 

  8. Howell SB, Pfeifle CE, Wung WE, Olshen: Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection. Cancer Res 43:1426–1431, 1983.

    Google Scholar 

  9. Howell SB, Taetle: Effect of sodium thiosulfate of cis-dichlorodiammineplatinum (II) toxicity and antitumor activity in L1210 leukemia. Cancer Treat Rep 64:611–616, 1980.

    Google Scholar 

  10. Ishizawa M, Taniguchi S, Baba T: Protection by sodium thiosulfate and thiourea against lethal toxicity of cis-diamminedichloroplatinum (II) in bacteria and mice. Jap J Pharmacol 31:883–889, 1981.

    Google Scholar 

  11. Sagiyama K, Uozumi J, Aoki K, Baba T: Efficacy of ‘two-route chemotherapy’ using intra-arterial cisplatin and IV sodium thiosulfate, its antidote, in rate bladder tumor. Cancer Treat Rep 67:567–572, 1983.

    Google Scholar 

  12. Shea M, Koziol JA, Howell SB: Kinetics of sodium thiosulfate, a cisplatin neutralizer. Clin Pharmacol Ther 35 (3):419–425, March, 1984.

    Google Scholar 

  13. Sunderman FW: The treatment of acute nickel carbonyl poisoning with sodium diethyldithiocarbamate. Ann Clin Res 3:182–185, 1971.

    Google Scholar 

  14. Newman EV, Gilman A, Philips FS: The renal clearance of thiosulfate in man. Bull Johns Hopkins Hosp 79:229–242, 1946.

    Google Scholar 

  15. Uozumi J, Ishizawa M, Iwamoto Y, Baba T: Sodium thiosulfate inhibits cis-diamminedichloroplatinum (II) activity. Cancer Chemother Pharmacol 13:82–85, 1984.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vance, R.B., Pittisapu, J. & Kappa, J.P. Experiences with sodium thiosulfate after intracarotid infusion of cisplatin and BCNU for malignant gliomas. J Neuro-Oncol 4, 151–154 (1986). https://doi.org/10.1007/BF00165375

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00165375

Keywords

Navigation